William Blair Initiates Coverage of Illumina with 'Outperform' Rating

The investment firm gave Illumina an "outperform" rating and an "aggressive growth" company profile.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.